Effects of NSAIDs on bladder function in normal and cystitis rats: A comparison study of aspirin, indomethacin, and ketoprofen

Journal of Pharmacological Sciences

Volumn 95, Issue 4, 2004, Pages 458-465

  Takagi Matsumoto, Hiroko ^a,b   Ng, Betty ^a   Tsukimi, Yasuhiro ^a   Tajimi, Masaomi ^a  

^a BAYER YAKUHIN LTD   (Japan)

^b BAYER PHARMA AG   (Germany)

Author keywords

Aspirin; Gastrointestinal lesion; Non steroidal anti inflammatory drug; Overactive bladder; Urodynamic parameter

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ARTICLE; BLADDER CAPACITY; BLADDER FUNCTION; COMPARATIVE STUDY; CYSTITIS; CYTOMETRY; DIGESTIVE SYSTEM INJURY; DRUG EFFECT; DRUG POTENCY; FEMALE; GASTROINTESTINAL MUCOSA; HUMAN; INTESTINE MUCOSA; MEASUREMENT; MICTURITION; NONHUMAN; PARAMETER; RAT; ULCEROGENESIS; URODYNAMICS;

EID: 4544388555     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FP0040098     Document Type: Article

References (24)

1. Lecci A, Birder LA, Meini S, Catalioto RM, Tramontana M, Giuliani S, et al. Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats. Br J Pharmacol. 2000;130:331-338.
2. Cardozo LD, Stanton ST, Robinson H, Hole D. Evaluation of flurbiprofen in detrusor instability. Br Med J. 1980;280:281-282.
3. Cardozo LD, Stanton ST. A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. J Urol. 1980;123:399-401.
4. Al-Waili ND. Diclofenac sodium in the treatment of primary nocturnal enuresis: double-blind crossover study. Clin Exp Pharmacol Physiol. 1986;13:139-142.
5. Al-Waili ND. Indomethacin suppository to treat primary nocturnal enuresis: double-blind study. J Urol. 1989;142:1290-1292.
6. Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci. 1986;31:1114-1122.
7. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology. 1987;93: 480-489.
8. Whittle BJ. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology. 1981;80:94-98.
9. Velasco C, Angelico P, Guarneri, L, Leonardi A, Clarke DE, Testa R. Effects of the nuclear factor-kappaB inhibitors 2-hydroxy-4- trifluoromethylbenzoic acid and aspirin on micturition in rats with normal and inflamed bladder. J Urol. 2001; 166:1962-1968.
10. Tsukimi Y, Mizuyachi K, Matsumoto H, Sato M, Ng B, Tajimi M. Mechanism of action by which aspirin alleviates detrusor hyperactivity in rats. J Pharmacol Sci. 2004;5:101-107.
11. Takeuchi K, Tanaka A, Suzuki K, Mizoguchi H. Gastrointestinal sparing anti-inflammatory drugs-effects on ulcerogenic and healing responses. Curr Pharm Des. 2001;7:49-69.
12. Dammann HG, Burkhardt F, Wolf N. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions. Aliment Pharmacol Ther. 1999;13:1109-1114.
13. Lecci A, Giuliani S, Santicioli P, Maggi CA. Involvement of spinal tachykinin NK1 and NK2 receptors in detrusor hyperreflexia during chemical cystitis in anaesthetized rats. Eur J Pharmacol. 1994;259:129-135.
14. Takeuchi K, Hase S, Mizoguchi H, Komoike Y, Tanaka A. Protection by aspirin of indomethacin-induced small intestinal damage in rats: mediation by salicylic acid. J Physiol Paris. 2001;95:51-57.
15. Doi T, Kamo I, Imai S, Okanishi S, Ikeura Y, Natsugari H. Effects of TAK-637, a tachykinin receptor antagonist, on the micturition reflex in guinea pigs. Eur J Pharmacol. 2000;395: 241-246.
16. Maggi CA, Evangelista S, Grimaldi G, Santicioli P, Giolitti A, Meli A. Evidence for the involvement of arachidonic acid metabolites in spontaneous and drug-induced contractions of rat urinary bladder. J Pharmacol Exp Ther. 1984;230:500-513.
17. De Groat WC, Yoshimura N. Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxico. 2001;41:691-721.
18. Cox PJ, Abel G. Cyclophosphamide cystitis. Studies aimed at its minimization. Biochem Pharmacol. 1979;28:3499-3502.
19. Lecci A, Meini S, Tramontana M, Giuliani S, Criscuoli M, Maggi CA. Kinin B1 receptor-mediated motor responses in normal or inflamed rat urinary bladder in vivo. Regul Pept. 1999;80:41-47.
20. Maggi CA, Lecci A, Santicioli P, Del Bianco E, Giuliani S. Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents. J Auton Nerv Syst. 1992;38:201-208.
21. Park JM, Yang T, Arend U, Smart AM, Schnermann JB, Briggs JP. Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction. Am J Physiol. 1997;273:F538-F544.
22. Bley KR, Hunter JC, Eglen RM, Smith JA. The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol Sci. 1998;19:141-147.
23. Komoike Y, Takeeda M, Tanaka A, Kato S, Takeuchi K. Prevention by parenteral aspirin of indomethacin-induced gastric lesions in rats: mediation by salicylic acid. Dig Dis Sci. 2002;47:1538-1545.
24. Takeuchi K, Ueshima K, Hironaka Y, Fujioka Y, Matsumoto J, Okabe S. Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Relation to gastric hypermotility. Digestion. 1991;49:175-184.